Administrative Core

摘要 行政核心 (ADM) 将对我们的第三阶段 COBRE 发挥整体监督作用。它是 由指导委员会、外部和内部咨询委员会以及其他利益相关者组成。 ADM 核心将由当前提案的 PI 文斯·卡尔霍恩 (Vince Calhoun) 博士指导。它还将在 由备受尊敬的精神病学临床医生兼研究员 Juan Bustillo 博士和 Nora Perrone-Bizzozero 博士（一位 著名的神经科学家和教育家。博士。 Jeff Lieberman（医学博士）和 Charles Bowden（医学博士）将担任 外部顾问。核心总监将协调 ADM 核心的职责和目标，重点关注三个目标： 1) 协调三个技术核心所需的所有具体预算、监管和人事方面 和试点项目计划； 2）建立强大的社区外展计划并支持新的研究者项目 使用我们的试点项目核心； 3) 与各方协商维护并继续开发重要的核心设施 内部和外部顾问。第三阶段合同的长期目标是扩大我们设施的能力 进一步发展多元化的、持续具有竞争力的神经影像研究环境 国内和国际。我们相信，通过 COBRE 第三阶段的支持，我们的凝聚力和 跨学科和转化研究的合作项目可以纳入中心级资助（例如 P41、 P50），将在第三阶段资助开始后大约 3 年后提交。因此，本次三期 该奖项对于我们新墨西哥州神经精神多模态成像项目的全面成功至关重要 疾病。

Abstract The administrative core (ADM) will function in an overall supervisory capacity for our Phase III COBRE. It is comprised of a steering committee, external and internal advisory committees, and other stakeholders. The ADM core will be directed by Dr. Vince Calhoun, the PI for the current proposal. It will also operate under the supervision of a well-respected psychiatric clinician-researcher, Dr. Juan Bustillo, and Dr. Nora Perrone-Bizzozero, an established neuroscientist and educator. Drs. Jeff Lieberman, MD and Charles Bowden, MD will serve as external consultants. The core director will coordinate the duties and goals of the ADM core, focused on three aims: 1) to coordinate all the specific budgetary, regulatory, and personnel aspects required in the three technical cores and Pilot Project Program; 2) set up a strong community outreach program and support new investigator projects using our pilot project core; and 3) maintain and continue to develop vital core facilities in consultation with internal and external advisors. A long-term aim of this Phase III award is to expand the capability of our facilities and further develop a diversified neuroimaging research environment that will continue to be competitive nationally and internationally. We believe that through the support of a COBRE Phase III, our cohesive and collaborative program of interdisciplinary and translational research can be leveraged into a center-level grant (e.g. P41, P50) which will be submitted approximately 3 years after the start of the Phase III award. Hence, this Phase III award is essential for the overall success of our New Mexico program on multimodal imaging of neuropsychiatric illness.